Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of British Columbia

$51,700.00

Integrated technologies and platforms for separation and characterization of biological analytes

EF 2007-08

Résumé
Our ever-expanding knowledge of the entire inventory of gene products within organisms and cell types is catalyzing explosive growth in products derived from biotechnology.  To facilitate these advances, research engineers are increasingly being called upon either to develop new methods and instrumentation that accelerate the discovery process, or to design and validate processes that convert a ground-breaking discovery into a commercial product or technology.  In particular, biotechnology companies concerned with production of therapeutics are constantly searching for effective purification technologies applicable to a range of products.  My ongoing research will address this need by providing new purification platforms designed to streamline downstream processing and improve product yields of recombinant protein therapeutics, including monoclonal antibodies (MAbs).  PM-based polymer brushes synthesized by ATRP chemistry will provide a family of novel high-capacity chromatography resins.  Controlled shear affinity filtration technology will be scaled up and applied to direct capture and affinity purification of MAbs produced by perfusion culture.  The need to accelerate protein discovery and improve disease diagnostics will be addressed through development of two new high-throughput platforms for resolving, indexing and annotation of the blood plasma proteome.  The first fuses a novel SPE resin for selective capture of glycoproteins with LC/MS/MS to provide an automated platform for blood plasma proteomics and disease diagnostics.  The second provides a multiplexed multidimensional HPLC platform for analyzing the blood plasma proteome without the need for protein denaturation, thereby creating a wealth of new knowledge related to blood and its components, including protein-protein and protein-ligand interaction partners in blood. Finally, we will further accelerate discovery of important gene-product functions through a new technology for structural proteomics that permits massively parallel expression and purification of cDNA-encoded gene products using cellulose-binding-module affinity tags.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
155176-2006
Name nom
Haynes, Charles
Department département
Michael Smith Laboratories
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
51700
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
2
Nb partie
5
Application title
Integrated technologies and platforms for separation and characterization of biological analytes
Keyword
NA
Application summary
Our ever-expanding knowledge of the entire inventory of gene products within organisms and cell types is catalyzing explosive growth in products derived from biotechnology.  To facilitate these advances, research engineers are increasingly being called upon either to develop new methods and instrumentation that accelerate the discovery process, or to design and validate processes that convert a ground-breaking discovery into a commercial product or technology.  In particular, biotechnology companies concerned with production of therapeutics are constantly searching for effective purification technologies applicable to a range of products.  My ongoing research will address this need by providing new purification platforms designed to streamline downstream processing and improve product yields of recombinant protein therapeutics, including monoclonal antibodies (MAbs).  PM-based polymer brushes synthesized by ATRP chemistry will provide a family of novel high-capacity chromatography resins.  Controlled shear affinity filtration technology will be scaled up and applied to direct capture and affinity purification of MAbs produced by perfusion culture.  The need to accelerate protein discovery and improve disease diagnostics will be addressed through development of two new high-throughput platforms for resolving, indexing and annotation of the blood plasma proteome.  The first fuses a novel SPE resin for selective capture of glycoproteins with LC/MS/MS to provide an automated platform for blood plasma proteomics and disease diagnostics.  The second provides a multiplexed multidimensional HPLC platform for analyzing the blood plasma proteome without the need for protein denaturation, thereby creating a wealth of new knowledge related to blood and its components, including protein-protein and protein-ligand interaction partners in blood. Finally, we will further accelerate discovery of important gene-product functions through a new technology for structural proteomics that permits massively parallel expression and purification of cDNA-encoded gene products using cellulose-binding-module affinity tags.